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Dr. Philip Fisher 
Given the known negative effects associated with prenatal exposure, it is 
imperative that babies presenting with symptoms are identified and receive treatment 
without delay. Women’s perceptions of how their child is affected by prenatal exposure 
likely impacts seeking and engaging with support services. However, little research has 
been conducted investigating the beliefs of women who used substances during 
pregnancy about the way that their children were impacted.  
The present study evaluates women’s concerns about their baby’s functioning, 
using a new measure. This measure, the Prenatal Exposure Concern for Functioning 
Scale (PECFS), identifies perceptions of baby’s current functioning and worries about 
future functioning. Analyses explore factors associated with increased concern. 
Findings suggest that women who used illicit substances during pregnancy generally 
report less concern for the current impact on their child than concern reported about 
future functioning due to prenatal exposure. Results also suggest that women who used 
the combination of methamphetamines and heroin report higher concern than women 
who did not use this combination of substances in pregnancy. These women could be 





include cultural beliefs and stigmas associated with these two substances and the 
individuals who use them. These cultural beliefs could potentially impact a woman’s 
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Decades of research document the negative impact of substance use during 
pregnancy on child outcomes. Using drugs while pregnant is detrimental to the health of 
both mother and fetus. Given the negative impact of continued substance use in 
pregnancy, it is imperative that women access the services and support systems that 
they need to stop using drugs and alcohol as soon as possible during pregnancy. 
Unfortunately, women who use drugs during pregnancy face uniquely difficult 
challenges to accessing these treatment services.  
One of the most troubling barriers to care is simply that very few treatment 
programs exist to accommodate pregnant and parenting women. In 2005, only 19% of 
treatment facilities nationwide offered programs specific to the needs of pregnant or 
parenting women (Walz & Bleuer, 2015). For example, treatment centers do not offer 
beds reserved for parenting women, nor do they offer childcare. A lot of treatment 
programs do not allow children; if a pregnant woman gives birth while in treatment, her 
infant could be removed from her custody, in part due to lack of resources for having an 
infant stay at the treatment center.  
For women who have young children already, accessing treatment programs that 
offer child-care services can also be difficult; availability of such services is frequently 
insufficient. When these services do exist, lack of transportation prevents many of them 
from accessing these programs (Marsh, D’Aunno & Smith, 2000). When services are 
either nonexistent or out of reach, mothers with drug abuse issues and their children are 




Women who are pregnant also experience significant barriers to accessing 
prenatal care, vital for the health of both mother and child. Research suggests that many 
women who use substances during pregnancy recognize the importance of prenatal care, 
but fear the possibility of reporting maternal substance use to child welfare or criminal 
justice systems (Jessup et al., 2003). Receiving support or advocacy from healthcare 
providers for this population is difficult due to biases. This increases the risk of 
inadequate care for mothers with substance abuse issues seeking treatment options.  
Women’s fear of legal action is also well a well-founded and notable barrier to 
accessing care. July 1989 was the first time in the US that a woman was criminally 
convicted for exposing her baby to drugs in utero (Roberts, 1991). According to Wright 
and Walker (2007), women who use drugs during pregnancy are much more likely to 
become involved in the criminal justice and child welfare systems. Thirty-five states 
have criminally prosecuted women for substance abuse or alcohol use during pregnancy 
(Jos, Perlmutter & Marshall, 2003). Women report that threat of disciplinary action 
such as loss of infant custody; threat of arrest and incarceration presents a significant 
obstruction to pursuing care. 
These concerns have increased during recent decades. Eighteen states now 
consider substance use during pregnancy to be child abuse. In Tennessee, women who 
use drugs while pregnant can be charged with criminal homicide, a Class A felony, if 
her actions result in the death of her baby (Paltrow & Flavin, 2013). If a pregnant 
woman discloses her use to a doctor in order to seek counsel in finding treatment 
services in this state, she could be arrested, and if convicted, be subject to a jail sentence 




However, regardless of the increased judicial system and child welfare 
consequences for substance use in pregnancy across the US, recent statistics indicate 
that the prevalence of substance use in pregnancy has increased (National Institute on 
Drug Abuse, 2011). Trends show that increased consequences of substance use during 
pregnancy occurred alongside a higher prevalence of this use. Thus, suggesting that 
harsh punishments are not encouraging women to cease use of substances while 
pregnant, which poses a greater risk to babies for prenatal exposure. Numerous 
researchers have written in opposition of increased consequences for women who use 
during pregnancy, noting that these consequences create greater unnecessary roadblocks 
to accessing services that help women address their addictions.  
Many women decrease their use of substances over the course of pregnancy on 
their own. This indicates that some women who use illicit drugs are concerned enough 
about their babies that they are able to mitigate their use as the pregnancy continues. 
Recent studies have shown that many pregnant women who use substances employ 
harm reduction strategies such as tapering doses and attempting to get clean without 
outside help or seeking services (Flavin, 2002). Harm reduction relating to substance 
use refers to making intentional changes to lessen the negative consequences of drug 
use, often specifically and purposefully limiting use (Ritter and Cameron, 2005). 
Notably, women can engage in harm reduction strategies while not completely ceasing 
use. Even with continued use, at a lesser dose, this behavioral shift to reduce harm 
suggests that women are actively engaged in trying to protect their child from the 




It is particularly important to understand thought processes and perceptions of 
concern that impact women’s continued substance use during pregnancy. Motivated 
women may be more likely to employ harm reduction strategies on their own, while not 
seeking or not being able to access treatment. While employing harm reduction 
strategies is significant, it is imperative that pregnant women cease using substances as 
soon as possible for maternal and fetal health. A big part of facilitating this progress is 
specific knowledge and education about effects of prenatal exposure; individuals must 
be able to recognize harm associated with behaviors before positive change can occur 
(Ajzen & Fishbein, 1977). Clearly women who are cutting back on their drug use are 
recognizing harm and facilitating positive change on some level, but it is important to 
delve further into women’s perceptions of how illicit drugs are affecting their babies.  
Much research has been conducted on perceived risk and knowledge about use 
of cigarettes and alcohol while pregnant, but less is known about perceptions of dangers 
associated with prenatal exposure to illicit substances (Perry, Jones, Tuten & Svikis, 
2003). Most women are familiar with risks associated with ingesting alcohol while 
pregnant because the federal government mandates that products containing alcohol 
have health-warning labels on them (Hankin et al., 1993). Illicit substances obviously 
do not contain such warnings and information. Women may understand that substances 
are not healthy for a developing fetus, but not the extent to which these drugs could be 
harming their babies. Learning more about how women conceptualize the effects of 
their drug use on their pregnancies may be helpful in elucidating ways to help women 





Given the potentially deleterious effects of prenatal exposure, it is vital to 
understand how women perceive the risk of using substances while pregnant. It is key 
that these women are knowledgeable about specific effects of prenatal exposure, which 
include increased risk of miscarriage (Ness et al., 1999), low birth weight (Ostrea, 
Ostrea & Simpson, 1997), high risk of babies born with physical addiction (meaning 
they may go through withdrawal and require intensive neonatal medical treatment and 
extended hospital stays) (Pan & Yi, 2013), and developmental delays (Yip, Lacadie, 
Sinha, Mayes, & Potenza, 2016).  
Specifically, women who use substances during pregnancy put their babies at 
risk for having Fetal Alcohol Syndrome and Neonatal Abstinence Syndrome. Fetal 
Alcohol Syndrome refers to the range of effects that can occur in an individual whose 
mother drank alcohol during pregnancy. Neonatal Abstinence Syndrome refers to a 
collection of problems that occur in a newborn that was exposed to addictive illicit or 
prescription drugs while in utero. The lesser-known effects of Fetal Alcohol Syndrome 
also include observable physical traits, malformation of skeletal and major organ 
systems, central nervous system complications and problems with adaptive behavior 
(Streissguth et al., 2004). Neonatal Abstinence Syndrome refers to babies born with 
prenatal exposure to opiates.  Neonatal Abstinence Syndrome is characterized by a set 
of medical issues including withdrawal symptoms (including but not limited to muscle 
spasms, seizures, fever, sleep problems etc.) that a newborn may experience due to 
exposure to addictive substances. Fetal alcohol syndrome is perhaps the most 
recognized impact of prenatal exposure due to health warning label laws required in the 




government warnings stating “…women should not drink alcoholic beverages during 
pregnancy because of the risk of birth defects” (Mayer, Smith & Scammon, 1991). 
Unfortunately, despite negative consequences, the prevalence of substance use 
during pregnancy continues to increase. The number of infants born with Neonatal 
Abstinence Syndrome increased from 3.4 to 5.8 per 1000 hospital births from 2009 to 
2012, cumulating in a total of 21,732 babies diagnosed with Neonatal Abstinence 
Syndrome in 2012 alone (Patrick, Davis, Lehmann & Cooper, 2015).  
Given the poor outcomes that are associated with prenatal exposure, it is 
important that babies who present with symptoms receive treatment and support as early 
as possible. For children who have developmental or learning delays, access to 
intervention services can help support their development and enable them to thrive. 
Thus, it is important that the signs of prenatal exposure are recognized sooner rather 
than later by mothers who are caring for their babies so they are able to access care 




Goals of the Current Study 
This research study was designed to identify the perceptions and concerns of 
recovering mothers related to prenatal exposure. More specifically, this study identifies 
women’s perceptions of their own infants and young children given their drug use 
during pregnancy. This research will help to identify how women perceive the ways in 
which substance use during pregnancy has impacted their child while also identifying 
concerns women have about their child’s future development.  
Understanding women’s perceptions of harm to their children will inform 
services designed to support women with addictions and their children. Women’s 
perception of prenatal exposure likely strongly impacts seeking support services. If 
women do not perceive that their child is impacted by substance exposure, they may be 
less likely to seek support services for their child early on or to follow through with 
recommended referrals.  
Women’s perceptions of how their baby or young child is impacted may 
influence their concern about substance use during subsequence pregnancies. If women 
believe that their current child was not harmed by their use of substances during 
pregnancy, they may be less concerned about their use in later pregnancies. This may 
lead to decreased motivation to alter their use on their own or seek treatment services. 
In addition, women may find that their experiences sharply contrast with educational 
information about prenatal exposure offered by healthcare professionals. If women are 
warned that prenatal exposure leads to dangerous health concerns, yet they give birth to 




healthcare advice. This weakened trust may add to barriers associated with women 
seeking care for substance abuse. 
In addition, this research will evaluate the utility of a new measure, the Prenatal 
Exposure Concern for Functioning Scale (PECFS). This measure was designed based 
upon our own preliminary qualitative research that identified, through interviews, the 
kinds of concerns women have about for their babies following substance use during 
pregnancy. The PECFS measures women’s current level of concern based upon her 
perceptions and observations of her baby’s current functioning while also measuring 
concerns about the way prenatal exposure may impact the child in the future.  
 The PECFS measure is the first measure to quantify maternal concern based 
purely upon mother’s perceptions of impact due to prenatal exposure on their children. 
We hypothesize that mothers in treatment will perceive their babies as not having been 
affected by their drug use in pregnancy, but will express concern about the future 
development of their child. It is equally important to consider associations between 
concerns about prenatal exposure and other measures in order to possibly begin to 
understand factors associated with greater maternal concern.  
With the goal of identifying factors associated with greater or lesser concern, we 
considered whether differences in personal characteristics (i.e. search for presence of 
meaning in life, feelings of gratitude and feelings of hope) were associated with greater 
concern. These positive psychology measures were included due to theoretical 
associations between how women conceptualize their world. For example, if women 
express higher levels of gratitude, this may indicate a more positive worldview. If 




concern for their children. The impact of prenatal exposure is often particularly subtle, 
and we anticipated that maternal worldview might impact the way that women perceive 
their child as having been impacted.  
In addition, we investigated aspects of substance use during pregnancy 
hypothesizing that greater substance use would be related to greater concern. In 
particular, we considered the specific substances women reported using during 
pregnancy including whether or not women used alcohol, methamphetamines, heroin, 
marijuana and opiates. We hypothesized that mothers who used a combination of illicit 
substances would express higher concern about the effects of their drug use during 
pregnancy. Research suggests that policymakers and the general public often wrongly 
assume that the legal status of a drug is associated with the extent that the substance 
impacts the developing fetus (Thompson, Levitt & Stanwood, 2009). Thus, strong 
social stigmas associated with use of illicit substances while pregnant may influence 
women’s perception of whether or not their child is impacted by prenatal exposure. 
Therefore, a central goal of this study is to identify and quantify how women 
perceive their children as being affected by their drug use during pregnancy. Specific 
perceptions investigated include concerns about baby’s current functioning and 
concerns about future functioning and development. A subsequent goal of this research 
is to reveal associations between maternal concern about the effects of prenatal 
exposure and other measures in order to examine factors associated with greater 
concern.  
A long-term goal of this research is to develop information that can inform 




is designed to facilitate availability of information to women who may be less likely to 
seek services. Comprehending women’s perceptions enables services to build upon 
women’s current beliefs about the ways in which their children have been impacted, 









Participants include 33 women who used substances during a pregnancy within 
the past 4 years. Many of these women have more than one child; on average women 
have between two and three children besides the child who was a newborn around the 
time of entry into treatment (M=2.72). Women ranged from 19 to 39 years of age. The 
mean age for this sample (N=33) was 28.66 (SD=5.63). Women were recruited from an 
inpatient treatment center where they were currently receiving services. This treatment 
center is located in a medium-sized city in the Pacific Northwest. This integrated 
treatment facility focuses on addressing both substance abuse issues as well as 
providing pregnancy and parenting support. Most participants represented a high risk 
and low SES demographic, and were receiving Medicaid at the time that this research 
was conducted. 87% of participants completed high school or have a GED. One woman 
completed an associate’s degree and none of the mothers have completed a 
college/university bachelor’s degree. 69.7% of women report an annual gross household 
income of less than $4,999.  
When women entered treatment they indicated on their original intake 
paperwork whether or not they were interested in future research opportunities. Eligible 
women who expressed interest were presented with the option of participation. 
Participants were required to be conversant in English, at least 18 years old and 
currently receiving inpatient substance abuse treatment, have a history of using 





Informed consent was acquired in order to explain potential risks associated 
with participation and to discuss confidentiality. Given the sensitive nature of 
researching substance use in pregnancy, a National Institute of Health Certificate of 
Confidentiality was obtained for this research. The Certificate of Confidentiality was 
explained to participants, emphasizing extra measures of confidentiality. Women were 
informed that any identifiable information was kept within a locked office, in a locked 
building at all times. Instances in which it would be necessary to break confidentiality 
were clearly explained, citing cases of suspected use or neglect of a child or elderly 
person. The University of Oregon’s Institutional Review Board approved the study’s 
protocol and consent forms. 
Researchers set up times to meet with participants in private rooms within the 
treatment center in order to maintain confidentiality and facilitate comfortable child 
care for mothers with infants. Mothers were offered the option of childcare during 
participation. Participation in its entirety took approximately two and a half to three and 
a half hours and participants were compensated $35. 
Participants were offered the choice to complete the online questionnaire either 
by themselves, in a structured interview style, or using a combination of styles to ensure 
full comprehension of questions. At least one researcher accompanied each participant 
at all times.  
Polysubstance Use During Pregnancy 
Participants were asked about their use of tobacco, alcohol, marijuana, 
methamphetamine, heroin and other opiates during pregnancy. All participants reported 





substances individually, tobacco was the most commonly used substance in this 
population; 87.9% of participants reported that they were smoking cigarettes while 
pregnant. 78.8% of women reported using methamphetamine; making this substance the 
second most commonly used substance as well as the most commonly used illicit 
substance (see Table 1).   












Tobacco 29 87.9% 
Meth 26 78.8% 
Marijuana* 22 66.7% 
Opiates 15 45.5% 
Alcohol 13 39.4% 
Heroin 12 36.4% 
Table 1: Frequencies of substance use 
*Illicit substance at time of research 
 
The Prenatal Exposure Concern for Functioning Scale 
We developed a novel questionnaire, the Prenatal Exposure Concern for 
Functioning Scale, which was designed to identify and typify concerns that recovering 
mothers may have for their infants and young children given exposure to substances 
during pregnancy. This measure was informed by our preliminary qualitative research 
with women who used substances during pregnancy which suggests that women are 
aware of the dangers of using substances while pregnant, but do not necessarily 
currently perceive their child as having been affected by their use in pregnancy. This 





The first subscale is concentrated around concerns about the baby’s current 
functioning and the second subscale is focused on concerns about future functioning. 
The free response question asks women to consider ways in which their child has been 
affected by their drug use during pregnancy. All questions are self-report based upon 
individual perceptions, offering a parallel structure to the quantitative questions. The 
subscale focusing on baby’s current functioning includes questions about how the child 
acts, how the child thinks and how the mother perceives the child’s brain to be working. 
The subscale designed to measure concerns about future functioning includes questions 
focused around worries about future harm, worries about school, as well as concerns 
about how the baby is acting and thinking. Theoretically we had anticipated there being 
two different subscales to the PECFS questionnaire due to two different kinds of 
questions being asked. The first subscale relating to the baby’s current functioning 
includes the following three items; “My child acts differently because I used substances 
during pregnancy,” “My child’s brain works differently because I used substances 
during pregnancy,” and “My child thinks differently because I used substances during 
pregnancy.” 
The second subscale, measuring concerns about future functioning, contains six 
items, including “My substance use during pregnancy harmed my child,” “My child acts 
differently because I used substances during pregnancy,” “My child’s brain works 
differently because I used substances during pregnancy,” “My child thinks differently 
because I used substances during pregnancy,” “I worry that my child is going to have 





how my use of substances in pregnancy harmed my child.” (See Appendix A for the full 
questionnaire). 
Measures of Positive Psychology that may be associated with Maternal Concern 
for Prenatal Exposure 
In addition to administering the PECFS, we also asked participants to complete 
a number of positive psychology questionnaires designed to identify how women 
conceptualize their world. Thus enabling identification of whether positive affectivity 
impacted level of concern for impact of prenatal exposure. Positive affectivity is 
defined as positive emotional experience. Maternal concern for prenatal exposure was 
predicted to be associated with a number of other measures. These measures were 
considered due to theoretical relationships between women’s worldview and their level 
of concern for their babies. 
Meaning in Life Questionnaire 
The positive psychology measure Meaning in Life Questionnaire was 
considered. The Meaning in Life Questionnaire is a 10-item questionnaire that measures 
the extent to which individuals feel their lives have meaning and to what extent 
individuals endeavor to find and attribute meaningfulness to their lives. Responses to 
individual items are recorded on a 7-point Likert scale ranging from 1 (Absolutely 
True) to 7 (Absolutely Untrue) (Steger, Frazier, Oishi & Kaler, 2006). Combining 







The Gratitude questionnaire used to explore this framework was the Gratitude 
Questionnaire-Six Item Form, a short questionnaire designed to measure the experience 
of gratitude in individuals. The questionnaire is positively related to optimism, life 
satisfaction and empathy, while negatively related to depression, envy and anxiety. This 
questionnaire is comprised of six self-report measures which participants are required to 
answer on a 1 (strongly disagree) to 7 (strongly agree) Likert scale (McCullough, Tsang 
& Emmons, 2004). 
Adult Hope Scale 
The Adult Hope Scale was also used in order to explore whether women who 
scored higher on the scale would exhibit more maternal concern or less concern. The 
Adult Hope Scale is comprised of 12 items intending to measure participant’s level of 
hope. The scale is divided into two subscales; (1) agency toward hope, as defined by 
action taken towards goals and (2) hope pathways defined as plans to take actions 
towards goals. Subscales are combined to calculate a raw hope score. Responses are 
coded in an eight-point Likert scale ranging from 1 (definitely false) to 8 (definitely 






Exploratory Analyses of Prenatal Exposure Concern for Functioning Scale 
Variables in Sample 
Forty-six women completed this questionnaire which consisted of fourteen total 
items, nine of which required the response format in a 5-point Likert scale ranging from 
1 (strongly disagree) to 5(strongly agree) with a median of 3 (neither agree nor 
disagree). Mean responses ranged from 1.42-4.7 for individual items. See Table 2 for 
details on specific items.  
There is notable variation from one item to the next, with two items standing out 
of the normal distribution. Responses to the “My child looks differently…” and “I am 
very lucky to have such a healthy child…” items were non-normally distributed, with 
kurtosis of 3.47 (SE = .41) and 2.54 (SE = .41) respectively. 
The item that asks whether women believe their children look differently due to 
their use of substances in pregnancy reveals that few women believe that their child is 
physically impacted by prenatal exposure. No participants report strongly agreeing that 
their child looks differently. Two women report agreeing with this statement (6.1%), 
and two women are unsure (6.1%) whereas the majority of the sample (87.9%) disagree 
or strongly disagree). See Figure 1 for a visual representation of women’s responses to 
this question. To see a representation of an item that is more normally distributed, see 
Figure 2. Similarly, almost all women agree that they are “very lucky to have such a 
healthy child…” despite using substances. Only two women are unsure of whether or 





item. Given the way in which these two items differed from the other more normally 
distributed items, these two items were considered separately from the other items on 
the questionnaire that have a normal distribution.  
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Figure 2: Normal distribution of women that perceive effects of drug use while 
pregnant 
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“My substance use 
harmed my child” 
 
10 9 14 3.15 1.25 
“My child acts 
differently…” 
 
18 11 4 2.24 1.06 
“My child’s brain 
works differently…” 
 
17 11 5 2.36 1.06 
“My child thinks 
differently…” 
 
18 11 4 2.24 1.06 
“I worry that my 
child is going to have 
difficulties in school 
because I used…” 
 
12 9 12 2.88 1.14 
“I worry about how 




7 10 16 3.36 1.34 
“I worry my child is 
going to have an 
addiction because I 
used…” 
 
11 13 9 2.79 1.19 
“My child looks 
differently due to my 
substance use during 
pregnancy” 
 
29 2 2 1.42 .87 
“I am very lucky to 




2 0 4.7 .59 
Table 2: Women who express concern 





‘Do not express concern’ represents Strongly Disagree or Disagree responses. 
‘Undecided’ represents Neither Agree nor Disagree responses. ‘Express concern’ 
represents Agree or Strongly Agree responses. 
 
Reliability of the Prenatal Exposure Concern for Functioning Scale  
Cronbach’s alpha for the nine multiple-choice variables was .84, indicating that 
this scale is acceptably reliable. Alpha increases to .87 when the following items are 
removed; “My child looks differently…” “I am very lucky to have such a healthy child 
despite my use…” When these questions were removed, there were seven items 
remaining with an alpha of .87. Although the alpha of the original nine items was 
already quite high, these items were left out in order to create more cohesive subscales. 
Items addressing baby’s looks and luck for health were left out due to their non-normal 
distribution, which will be discussed further. 
Reliability of Sub-scales of Prenatal Exposure Concern for Functioning Scale 
Cronbach’s alpha for the subscale measuring concern for baby’s current 
functioning was .89, suggesting strong reliability. According to Button et al. (2013), 
with such a small sample size, the possibility of undermined reliability must be 
acknowledged, however an alpha reaching almost .90 is still significant. Cronbach’s 
alpha for the second sub-scale, measuring maternal concerns about future functioning, 






 Data Analysis and Coding 
There is one free response question included in the PECFS, which asks “In what 
ways do you believe your child has been affected by your drug use during pregnancy?” 
This question provides the opportunity for participants to express specific ways that 
they believe their child may have been harmed due to their substance use during 
pregnancy that quantitative questions do not address. 
Qualitative analyses of responses identify that responses can be grouped into 
four themes. These themes include: 1 concerns about the physical impact of prenatal 
exposure, 2 concerns about the baby’s observed current functioning, 3 concerns about 
the child’s future and 4 little to no concern. 
Ten women responded that this question was not applicable to them. Eight 
women responded in their own words that they had either not observed their child as 
having been affected by their drug use or did not believe their child had been affected. 






Theme 1: Physical Impact of Prenatal Exposure 
Participant Concern 
2006 Low birth weight, extra/many days in NICU, trouble gaining weight 
2033 n/a, other children have been effected; they had to withdrawal from 
methadone. Have not noticed anything beyond withdrawal. 
2039 I wonder if my kid was affected because she had a brain tumor, difficulties 
breast feeding 
 









Exaggerated startle reflex, slow to meet milestones 
Kind of ADHD …he’s not bipolar, but he’s got problems, some days he 
spaces out, and some days he’s really crazy; sensory integration problems 
 Doesn’t seem to experience pain the way most children do 
Not talking as much as he should 
I believe my daughter has been affected and has some learning disabilities  
ADHD 
Theme 3: Maternal concerns for child’s future 
2018 Mentally, because she has been [will be] in foster care 






...[afraid my child will be] put into harmful situations 
…they all grow up to be like us. 
…believe any type of drug use [during pregnancy] will affect the child 
[negatively], not sure how. 
Neglect, not having basic needs met, not having stable place to live or the 






Theme 4: No observed impact; little to no concern 
Participant Concern 
2014 So far no…he sleeps good, he eats good, he’s big, he’s 100% healthy 









 I don’t think she is old enough yet to tell if any of the drugs I had used 
affected her in any way 
I haven’t seen any signs, but they may come later 
None of my [other] kids came out with anything wrong with them. 
…no worries right now 
No 
Because I was an addict, I was able to access more care than I would have 
without treatment…She was affected positively by me being able to enter 
treatment early. 
Table 3: Ways in which mothers conceptualize how their babies have been harmed due 
to prenatal exposure 
Exploratory analyses of factors associated with the Prenatal Exposure Concern for 
Functioning Scale 
To understand more clearly why some women had greater concern about the 
impact of prenatal exposure than others, exploratory analyses were conducted. We were 
interested in identifying whether higher concern for baby’s current functioning and 
future development was associated with either women’s history of substance use during 
pregnancy or with personal attributes. Analyses indicated that when considering 
personal attributes with positive psychology measures, there were no significant 
correlations between women’s concerns for their babies given prenatal exposure and 
these measures.  
The Gratitude scale was neither significantly correlated with maternal concern 
for baby’s current functioning, r= -.272, n=33, p > .1, nor significantly correlated with 





nonsignificant correlation in the adult agency toward hope subscale, which measures 
goal-directed energy driven by feelings of hopefulness, and baby’s current functioning, 
r = -.068, n=33, p > .1 as well as concerns about baby’s future functioning, r = -.015, 
n=33, p > .1. The adult hope pathways subscale, which measures capabilities pertaining 
to planning to accomplish goals, also showed a similar nonsignificant relationship with 
baby’s current functioning; r = -.037, n=33 p > .1 and concerns about baby’s future 
functioning, r = -.033, n=33, p > .1. The Meaning in Life Questionnaire, which 
measures the extent to which mothers feel their lives have meaning, was also not 
significantly correlated with baby’s current functioning, r = -.169, n=33, p > .1 nor with 
concerns about future functioning, r = -.112, n=33 p > .1. 
Analysis of substance abuse history in relation to the Prenatal Exposure Concern 
for Functioning Scale 
Additional analyses considered whether maternal concern about effects of 
prenatal exposure is associated with maternal history of substance use in pregnancy. We 
anticipated that women who had a history of greater substance use would be more 
concerned about the impact of prenatal exposure. This could be related to cultural 
beliefs about the dangers of specific substances as well as the legal status of different 
substances. One way that we were able to test the amount of prenatal exposure was by 
considering the substances that women reported using during pregnancy. We grouped 
women based upon whether they used alcohol, methamphetamines, heroin, marijuana 
and opiates. We hypothesized that women who used both heroin and methamphetamine 
would have particularly high concern about the impact of their use on the baby due to 





this combination of substances may represent particularly detrimental illicit 
polysubstance use and lifestyle choices. 
T-test analyses indicate that when considering baby’s current functioning, 
women who used both meth and heroin while pregnant report greater concern  (M=2.9, 
SD=.70) than women who did not use this combination of substances during pregnancy 
(M=2.0, SD=.95) t(32)=2.7, p=.01. This indicates that on average women who use the 
combination of methamphetamine and heroin report neither agreeing nor disagreeing 
with whether their baby’s current functioning is impacted by their substances use in 
pregnancy, whereas women who did not use the combination of methamphetamine and 
heroin while pregnant on average report that they disagree that their child’s current 
functioning is impacted by their substance use in pregnancy.  
Regarding concerns about the baby’s future functioning, these women reveal a 
marginally significant increase in worry (M=3.1, SD=.60) in comparison to women who 
did not use both methamphetamine and heroin during pregnancy t(32)=1.97, p=.06 
(Mean=2.5, SD=.94). This suggests that on average women who use the combination of 
methamphetamine and heroin report neither agreeing or disagreeing with having 
concern for whether their baby’s future functioning will be impacted. In contrast, 








This study’s findings suggest that women who used illicit substances during 
pregnancy generally perceive their child as not being currently impacted by their use of 
substances during pregnancy. For example, when asked about whether women believe 
their baby has been affected by their drug use during pregnancy, the majority of women 
report that their babies have not been affected. Women did not report high levels of 
concern for their baby’s current functioning nor for their baby’s future functioning. 
When given the opportunity to list specific concerns about their child’s functioning 
related to exposure to substances use during pregnancy, some mothers expressed 
specific concerns in their own words. Example topics of concern include worries about 
their child having future difficulties in school, having mental health issues and having 
future drug abuse issues.  
The Prenatal Exposure Concern for Functioning Scale identifies concerns that 
recovering mothers have about their infants or young children who were exposed to 
illicit substances in utero. Statistical testing demonstrates reliability of the measure 
through evidence of a high Cronbach’s alpha. In addition, women’s responses to an 
open-ended question about their concerns reflect specific items on the PECFS. 
The PECFS was typified into two subscales. One subscale related to concern 
about baby’s current functioning. The second subscale related to future concerns about 
functioning. These subscales were also found to have high internal reliability. These 
subscales and therefore the measure in its entirety is mirrored in the responses to the 
open-ended qualitative question, “In what ways do you believe this child has been 





down thematically within this qualitative question mirrors the construction of the 
PECFS. These results indicate that the PECFS holds promise as a measure for obtaining 
source information about maternal concern related to current and future functioning of 
their babies given prenatal exposure. 
As hypothesized, women did not exhibit particularly strong beliefs about the 
effects that their drug use had on their babies. While women did address principle 
concerns about their baby’s current and future functioning when asked in a qualitative 
style, many of the questions in the PECFS yielded relatively neutral responses, clustered 
around women responding that they neither agree nor disagree with individual items. 
This held true for items that asked about concern for children having future addictions, 
observed differences in functioning such as acts differently and brain works differently 
as well as worry about ways that use of substances harmed the child. 
In contrast there were two items in which women expressed stronger opinions. 
These included the items, “My child looks differently…” and “I feel very lucky to have 
such a healthy child despite my use…” The majority of mothers (25 of 33 mothers) 
identified that they strongly disagree (represented by a 1 on the Likert scale) that their 
child looks differently due to their substance use in pregnancy. Almost all women 
strongly agree (5 on the Likert scale) that they feel very lucky to have a healthy child. 
These specific opinions are important to examine theoretically in order to discover what 
differentiates these topics from other perceptions of prenatal exposure impact.  
The lack of concern about the current impact of prenatal exposure could be 
related to a number of important factors and is an area ripe for further consideration. 





exposure could be due to women having an inaccurate view of the impact of prenatal 
exposure.  
Specifically, women may expect that prenatal exposure profoundly impacts the 
developing baby, not understanding that, in most instances, the impact of prenatal 
exposure is subtle in nature.  
This observation is significant because it may impact whether or not women 
seek out support services for their children. It may also influence the timing of seeking 
support. If mothers believe that prenatal exposure is related to dramatic physical 
differences in their baby’s appearance and are not seeing these differences, they may 
assume their child has not been affected by their use. This may impact access to early 
intervention, as mothers may be less likely to seek out these types of services if they 
believe that their child has not been impacted by their substance use.  
When asked about differences in how their babies look and when asked about 
whether or not they feel lucky about having a healthy baby, mothers’ responses showed 
a similar pattern. This pattern potentially stems from expectations mothers have of 
symptoms of prenatal exposure. All women agreed and most women felt strongly (5 on 
the Likert scale) about both items.  If women are reporting that they strongly disagree 
that their children look differently given prenatal exposure and that they are lucky to 
have a healthy child, this suggests that women believe their child is not impacted by 
their substance use. In the case of perceiving their children is being unaffected, women 
may be less inclined to seek out early intervention support services for their children.  
These perceptions were investigated further through the qualitative question, “In 





pregnancy?” In some cases, women did describe visible signs of exposure in 
conjunction with medical diagnoses, such as the baby going through withdrawal after 
birth. However, only three women specifically expressed concerns about the physical 
impact of prenatal exposure. This may be related to most babies not being impacted 
physically by prenatal exposure. For example, it is unlikely that most babies would go 
through this kind of withdrawal. This relatively low rate of concern may also relate to 
mothers not associating known complications at birth to prenatal exposure (Perry et al., 
2003). 
When creating the qualitative question, which asked women to list any concerns 
they have about their baby related to prenatal exposure, diction was considered 
carefully in order to produce maximum clarity and singularity of interpretation. Women 
expressed concerns that fit in with concerns surrounding the four themes addressed after 
the questionnaire was administered. Themes included concerns about physical impact, 
concerns about baby’s observed current functioning, concerns about child’s future 
functioning, and little to no concern.  
Four women identified with the theme of physical impact, citing observations 
such as low birth weight and low muscle tone. A greater number of women reported 
concerns about observed current functioning of their babies, such as being “kind of 
ADHD”. An equal number of women reported concerns about their child’s future. The 
responses that fit into subsequent themes become more diverse; from concerns about 
mental health issues, their babies being involved with social services, to future behavior 
and choices surrounding drug use. The fact that more women reported a greater number 





physical well-being helps support the claim that the two items “My child looks 
differently…” and “I am very lucky to have such a healthy child despite my use of 
substances in pregnancy” did not fit in with the either subscales of the PECFS. Within 
the context of the qualitative question specifically, women appear to be focusing more 
on future problems with their children because they do not identify with seeing effects 
of exposure at the time of research.  
Participant 2050 presented a distinctive response, indicating that she believes 
her use will have an effect at an unforeseen time, representing future concern, yet she 
also expressed that she has “no worries right now”. This participant exemplifies one of 
the dissonant thought patterns investigated; from this response, it would seem 
reasonable to deduce that women who have similar beliefs may not feel it necessary to 
access early intervention services for their babies. This sentiment appears to 
communicate the potential relationship of mothers experiencing concerns and seeing 
signs of prenatal exposure. It is necessary to begin to understand what could lead to 
feelings of greater concern in order to further explore how women perceive their 
children as being affected by prenatal exposure and subsequently access early 
intervention services.  
In order to begin trying to understand predictors of concern, analyses identifying 
the relationship between maternal concern and personal attributes were conducted. The 
Adult Hope questionnaire was used in order to analyze a potential relationship between 
concern and feelings of hopefulness. The Meaning in Life scale, which measures the 
extent to which individuals feel meaning and seek meaning, was also used to investigate 





which could be associated with more positive outlooks directed towards outcomes for 
their children (Taubman-Ben-Ari, Shlomo & Findler, 2012). Feelings of optimism, life 
satisfaction and empathy were also measured via a Gratitude Questionnaire. Our 
analyses did not find any significant relationships between positive psychology 
measures and concern. This finding was surprising, as we had anticipated that women 
with more positive affectivity would report less concern for their babies. This finding 
suggests that positive affectivity and outlook on life is unrelated to amount of concern 
women have on their babies given prenatal exposure. This also suggests that mothers 
could be basing their concern less on general emotion and affectivity and more on 
concrete logical reasons such as substance use history. 
Although this research suggests positive psychology measures are not 
significantly associated with maternal concern, the study identified that women who use 
both methamphetamine and heroin have greater concern about their baby’s current 
functioning as well as baby’s future functioning than women who do not use this 
combination of substances. This difference is clinically significant in that on average 
women who use both of these substances report that they neither agree nor disagree 
with whether their baby’s functioning is impacted by their substance use in pregnancy 
while women who do not use these two substances report disagreement on average that 
their child’s functioning has been affected by their use. 
Women who used a combination of methamphetamine and heroin specifically 
could be exhibiting more concern for their babies due to many reasons; for example, 
cultural beliefs and stigmas against these two drugs and individuals who use them, or 





perspective on how her use of these two substances impacted/will impact her child. 
While this is a significant finding, this pattern could be problematic if women who are 
using substances or other substance combinations that are potentially dangerous to a 
developing fetus are experiencing less concern. If women who report less concern are 
less likely to seek out early intervention services, this may suggest that women who 
report greater concern (i.e. women who used a combination of methamphetamines and 
heroin) may seek out these services earlier. Women expressing more concern may also 
be more vigilant about observing symptoms of prenatal exposure. 
	   	  
Limitations 
Although results of this research were significant, there are clear limitations to 
this study. Principally, the small sample size must be noted. Increasing the sample size 
of the study would add power to statistical analyses, which could help to identify the 
associations between maternal concern and substance use patterns. A second limitation 
of this study is that results may not generalize to other women who use substances 
during pregnancy. Participants were recruited from a single treatment center in the 
Pacific Northwest that provides services for primarily low-income women. 
Additionally, the majority of women in this sample used methamphetamine. Use of this 
substance varies considerably across the United States. Thus, the participants in this 
study may differ from other women who used substances during pregnancy. It is of note 
that most women were Caucasian, low SES and primarily methamphetamine users. Due 







In light of the fact that this is the first study we know of specifically addressing 
level of maternal concern for prenatal exposure, there are multiple possibilities for 
future research. Replicating or conducting similar research in varying community 
environments and regions is necessary to understand suggested trends further. This is 
necessary due to demographics associated with the specific area research was 
conducted. It would be compelling to explore potential differences in maternal concern 
for babies given prenatal exposure with differing population attributes, such as women 
of color or women struggling with addictions to different substances.  
As it is likely that women’s’ perceptions of prenatal exposure impact seeking 
support services, it is paramount to find ways to better support women in addressing 
specific concerns for their babies given prenatal exposure. A logical next step would be 
to investigate a potential relationship between maternal concern and when or how 
women begin seeking services. Research investigating the impact of maternal concern 
for babies due to prenatal exposure and beneficial behaviors to seek out services to 
mitigate these effects is lacking.  
Results of this research suggest that women perceive their children as not 
impacted by prenatal substance exposure, women may be less likely to seek support 
services for their children early on. Future research can investigate whether maternal 
concern for effects of prenatal exposure is related to the likelihood of mothers seeking 
out support services, the timing of seeking out these services, and whether they follow 





If polysubstance use, and the combination of heroin and methamphetamine in 
particular, were a strong predictor for maternal concern as this research suggests, it 
would be particularly beneficial to see if women who express more concern are seeking 
out services earlier or later than women who are using other substances or other 
substance combinations. Beginning to understand trends in women’s concerns for their 
children given prenatal exposure is the first step in supporting them in seeking early 







Prenatal Exposure Concern for Functioning Scale 
 
Item Response 
1. My substance use during 
pregnancy harmed my 
child. 
1 – strongly disagree 
2 – disagree 
3 – neither agree nor disagree 
4 – agree 
5 – strongly agree	  
2. My child looks 
differently because I used 
substances during 
pregnancy 
1 – strongly disagree 
2 – disagree 
3 – neither agree nor disagree 
4 – agree 
5 – strongly agree 
3. My child acts differently 
because I used substances 
during pregnancy 
1 – strongly disagree 
2 – disagree 
3 – neither agree nor disagree 
4 – agree 
5 – strongly agree	  
4. My child’s brain works 
differently because I used 
substances during 
pregnancy 
1 – strongly disagree 
2 – disagree 
3 – neither agree nor disagree 
4 – agree 
5 – strongly agree	  
5. My child thinks 
differently because I used 
substances during 
pregnancy 
1 – strongly disagree 
2 – disagree 
3 – neither agree nor disagree 
4 – agree 
5 – strongly agree	  
6. I worry that my child is 
going to have difficulties in 
childhood because I used 
substances during 
pregnancy 
1 – strongly disagree 
2 – disagree 
3 – neither agree nor disagree 
4 – agree 
5 – strongly agree	  
7. I worry about how my 
use of substances in 
pregnancy harmed my child 
1 – strongly disagree 
2 – disagree 
3 – neither agree nor disagree 
4 – agree 
5 – strongly agree	  





going to have an addiction 
because I used substances 
in pregnancy 
2 – disagree 
3 – neither agree nor disagree 
4 – agree 
5 – strongly agree	  
9. My child was not 
harmed by my substance 
use in pregnancy 
1 – strongly disagree 
2 – disagree 
3 – neither agree nor disagree 
4 – agree 
5 – strongly agree	  
10. I am very lucky to have 
such a healthy child despite 
my use of substances in 
pregnancy 
1 – strongly disagree 
2 – disagree 
3 – neither agree nor disagree 
4 – agree 
5 – strongly agree	  
*In what ways do you 
believe this child has been 
affected by your drug use 
during pregnancy? 
(open response, with option of “I don’t believe that my 
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